Indefinite Delivery Contract SPE2DB24D9802

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at up to $499,999,999, runs through December 31, 2025 under the SPE2DB program. It allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have any set-aside designations. Through this vehicle, DMS Pharmaceutical Group provides a vast array of medications across multiple therapeutic classes to support the diverse medical needs of military personnel and their dependents at various Department of Defense (DoD) healthcare facilities. This IDC complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites.